Plasma Biomarkers and Clinical Indicators for Identifying Mild Cognitive Impairment in Older Adults With Psychiatric Disorders.
The findings suggest that integrating cognitive, psychiatric, and biomarker assessments may improve early detection of dementia risk in older adults receiving psychiatric treatment.